| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 8 2610-2617, Copyright © 1991 by American Association of Immunologists
ARTICLES |
GA Wilbanks and JW Streilein
Department of Microbiology and Immunology, University of Miami School of Medicine, FL 33136.
The anterior chamber of the eye is an immunologically privileged site. Recent evidence indicates that this privilege is an actively acquired immune state in which a unique form of systemic immune deviation exists, anterior chamber-associated immune deviation (ACAID). ACAID is characterized in part by the generation of Ag-specific splenic T lymphocytes that mediate suppression of induction and expression of delayed hypersensitivity and that suppress production of C-fixing antibodies. Delayed hypersensitivity and C fixation are usually associated with extensive nonspecific inflammation and innocent bystander tissue injury. It is, therefore, believed that ACAID represents physiologic adaptations of the immune system that mitigate wanton destruction of the anatomically delicate visual axis, thereby preserving sight, while at the same time providing selective immune protection. As a means of examining the potential contribution of the eye to ACAID induction, we have studied the immune properties of blood harvested from mice that had received BSA into the anterior chamber 48 h earlier. We found that an Ag-specific "signal" is present in the blood of these mice; when blood was transfused into naive syngeneic mice, regulatory cell populations were induced and the recipients were unable to display BSA-specific delayed hypersensitivity. Further analysis of this signal revealed it to be associated with the leukocyte fraction, but not with either the plasma or RBC components of whole blood. Among leukocytes, the suppression-inducing activity correlated positively with cells bearing the mature macrophage marker F4/80 and negatively with cells bearing Thy-1, surface Ig, and class II MHC molecules. These findings are discussed with regard to the potential intraocular sources of the ACAID-inducing signal and the possible mode of action of this factor.
This article has been cited by other articles:
|
|
 |
|
  K.-H. Sonoda, T. Nakamura, H. A. Young, D. Hart, P. Carmeliet, and J. Stein-Streilein NKT Cell-Derived Urokinase-Type Plasminogen Activator Promotes Peripheral Tolerance Associated with Eye J. Immunol., August 15, 2007; 179(4): 2215 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang-Hoover, P. Finn, and J. Stein-Streilein Modulation of Ovalbumin-Induced Airway Inflammation and Hyperreactivity by Tolerogenic APC J. Immunol., December 1, 2005; 175(11): 7117 - 7124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Lin, D. E. Faunce, M. Stacey, A. Terajewicz, T. Nakamura, J. Zhang-Hoover, M. Kerley, M. L. Mucenski, S. Gordon, and J. Stein-Streilein The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance J. Exp. Med., May 16, 2005; 201(10): 1615 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tsukahara, M. Takeuchi, H. Akiba, T. Kezuka, K. Takeda, Y. Usui, M. Usui, H. Yagita, and K. Okumura Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation Int. Immunol., May 1, 2005; 17(5): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kitaichi, K. Namba, and A. W. Taylor Inducible immune regulation following autoimmune disease in the immune-privileged eye J. Leukoc. Biol., April 1, 2005; 77(4): 496 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Camelo, A. Shanley, A. S. P. Voon, and P. G. McMenamin The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye J. Immunol., May 1, 2004; 172(9): 5388 - 5395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Faunce, A. Terajewicz, and J. Stein-Streilein Cutting Edge: In Vitro-Generated Tolerogenic APC Induce CD8+ T Regulatory Cells That Can Suppress Ongoing Experimental Autoimmune Encephalomyelitis J. Immunol., February 15, 2004; 172(4): 1991 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. F. H. M. Boonman, G. J. D. van Mierlo, M. F. Fransen, K. L. M. C. Franken, R. Offringa, C. J. M. Melief, M. J. Jager, and R. E. M. Toes Intraocular Tumor Antigen Drains Specifically to Submandibular Lymph Nodes, Resulting in an Abortive Cytotoxic T Cell Reaction J. Immunol., February 1, 2004; 172(3): 1567 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Camelo, A. S. P. Voon, S. Bunt, and P. G. McMenamin Local Retention of Soluble Antigen by Potential Antigen-Presenting Cells in the Anterior Segment of the Eye Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5212 - 5219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Skelsey, E. Mayhew, and J. Y. Niederkorn Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune Deviation Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5242 - 5251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Streilein Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation J. Leukoc. Biol., August 1, 2003; 74(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Mo, M. G. Anderson, M. Gregory, R. S. Smith, O. V. Savinova, D. V. Serreze, B. R. Ksander, J. W. Streilein, and S. W.M. John By Altering Ocular Immune Privilege, Bone Marrow-derived Cells Pathogenically Contribute to DBA/2J Pigmentary Glaucoma J. Exp. Med., May 19, 2003; 197(10): 1335 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Faunce and J. Stein-Streilein NKT Cell-Derived RANTES Recruits APCs and CD8+ T Cells to the Spleen During the Generation of Regulatory T Cells in Tolerance J. Immunol., July 1, 2002; 169(1): 31 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Masli, B. Turpie, K. H. Hecker, and J. W. Streilein Expression of Thrombospondin in TGF{beta}-Treated APCs and Its Relevance to Their Immune Deviation-Promoting Properties J. Immunol., March 1, 2002; 168(5): 2264 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Ng and J. W. Streilein Light-Induced Migration of Retinal Microglia into the Subretinal Space Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3301 - 3310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. N. A. Klaren and R. Peek Evidence for a Compartmentalized B Cell Response as Characterized by IgG Epitope Specificity in Human Ocular Toxoplasmosis J. Immunol., December 1, 2001; 167(11): 6263 - 6269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Skelsey, J. Mellon, and J. Y. Niederkorn {{gamma}}{{delta}}T Cells Are Needed for Ocular Immune Privilege and Corneal Graft Survival J. Immunol., April 1, 2001; 166(7): 4327 - 4333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. D'Orazio, E. Mayhew, and J. Y. Niederkorn Ocular Immune Privilege Promoted by the Presentation of Peptide on Tolerogenic B Cells in the Spleen. II. Evidence for Presentation by Qa-1 J. Immunol., January 1, 2001; 166(1): 26 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Faunce, K.-H. Sonoda, and J. Stein-Streilein MIP-2 Recruits NKT Cells to the Spleen During Tolerance Induction J. Immunol., January 1, 2001; 166(1): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kezuka and J. W. Streilein Analysis of In Vivo Regulatory Properties of T Cells Activated In Vitro by TGF{beta}2-Treated Antigen Presenting Cells Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1410 - 1421. [Abstract] [Full Text]
|
|
|
|
|
|
M. Yoshida, M. Takeuchi, and W. Streilein Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 811 - 821. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. W. STREILEIN, S. OKAMOTO, Y. SANO, and A. W. TAYLOR Neural Control of Ocular Immune Privilege Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 297 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G McMenamin Dendritic cells and macrophages in the uveal tract of the normal mouse eye Br. J. Ophthalmol., May 1, 1999; 83(5): 598 - 604. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Kosiewicz, P. Alard, and J. W. Streilein Alterations in Cytokine Production Following Intraocular Injection of Soluble Protein Antigen: Impairment in IFN-{gamma} and Induction of TGF-{beta} and IL-4 Production J. Immunol., November 15, 1998; 161(10): 5382 - 5390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Streilein ENHANCED PERSPECTIVE: Unraveling Immune Privilege Science, November 17, 1995; 270(5239): 1158 - 1158. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
